Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Off-label use Stories

2014-04-08 23:32:37

No-cost consultations from a national network of attorneys are now available to consumers of all ages who may be seeking compensation over allegations of gynecomastia, other side effects. San Diego, CA (PRWEB) April 08, 2014 http://www.resource4thepeople.com/defectivedrugs/risperdal.html Resource4thePeople announced today that its national network of attorneys has expanded its free legal consultations over allegations that the antipsychotic medication Risperdal may cause a breast-growth...

2014-03-20 23:29:36

National network of attorneys initiates offer of no-cost consultations to consumers seeking compensation for allegations of gynecomastia, other side effects. San Diego, CA (PRWEB) March 20, 2014 http://www.resource4thepeople.com/defectivedrugs/risperdal.html Resource4thePeople announced today that its national network of attorneys is now investigating claims over allegations that the antipsychotic medication Risperdal may cause a breast-growth condition known as gynecomastia or other side...

2013-11-04 16:29:43

LA JOLLA, Calif., Nov. 4, 2013 /PRNewswire/ -- The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, placebo-controlled, double blind clinical trial conducted by scientists at The Scripps Research Institute (TSRI). "Gabapentin's effect on drinking outcomes is at least as large or greater than those of existing...

2013-09-30 23:02:42

The U.S. Food and Drug Administration reports it has notified health professionals about a new Black Box warning for Pfizer Inc.'s intravenous antibacterial drug Tygacil (tigecycline). The FDA says the warning ramp-up is based on additional analysis the regulator conducted on the drug that reveals it is causing an increased mortality rate among users, Parker Waichman LLP cautions. New York, New York (PRWEB) September 30, 2013 Parker Waichman LLP, a national law firm dedicated to...

2013-07-05 23:00:52

Parker Waichman LLP is concerned that the public has not been properly educated about the clinically proven potential side effects that could result from Medtronic’s Infuse bone graft product. At the same time, the product continues to be used in ways for which it wasn’t approved, which only heightens the risks of side effects for patients undergoing these procedures. New York, New York (PRWEB) July 05, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights...

2013-06-26 12:31:40

A Drug's Label and Reimbursement Barriers are Factors that Impact Medical Oncologists' Sequential Prescribing of Targeted Agents, According to a New Report from Decision Resources BURLINGTON, Mass., June 26, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for metastatic colorectal (mCRC), a majority of surveyed oncologists most frequently prescribe a regimen containing...

2013-06-21 23:01:55

Johnson & Johnson is appealing the $1.2 billion fine issued by an Arkansas court over off-label marketing claims the company supposedly made regarding its antipsychotic drug Risperdal. However, a large number of Arkansas lawmakers are supporting the fine, and Parker Waichman LLP applauds their efforts as it continues to offer free legal advice to patients who took Risperdal, which has been associated with side effects such as male breast enlargement (gynecomastia). New York, NY (PRWEB)...

2013-04-17 16:49:13

Review finds little difference between effectiveness of drugs routinely prescribed for migraine prevention but evident difference in the side-effects experienced Migraine headaches are a major cause of ill health and a reduced quality of life. Some individuals suffer from a frequent and severe migraine problem which means that they require regular medication to try and prevent them. A new review´ of the medications, which may help to prevent episodic migraines, appears in the Journal...

2012-11-06 03:51:36

Special issue honors Frances O. Kelsey, pioneer in drug safety and regulation Pharmaceutical health services research goes beyond studying the effects of individual drugs, to looking at the complex and interrelated effects of medications on the health of patients and the population. The special November issue of Medical Care highlights important new papers in key areas of pharmaceutical health services research. The journal is published by Lippincott Williams & Wilkins, a part of...

2012-10-25 15:24:34

BALTIMORE, Oct. 25, 2012 /PRNewswire/ -- The healthcare fraud case that Boehringer Ingelheim Pharmaceuticals Inc. settled today with the government for $95 million was due in large measure to a former Boehringer Ingelheim sales representative-turned-whistleblower who made extraordinary efforts to stop Boehringer Ingelheim's pharma marketing practices that allegedly defrauded Medicare and other government healthcare programs and promoted uses of its drugs that endangered patients'...